Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study
The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for...
Saved in:
Published in | Frontiers in endocrinology (Lausanne) Vol. 13; p. 882148 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
02.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.Clinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.MethodsClinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.Seven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.ResultsSeven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.The online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.ConclusionThe online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA. |
---|---|
AbstractList | The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.Clinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.MethodsClinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.Seven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.ResultsSeven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81-0.87), 0.814 (95% CI: 0.77-0.86), and 0.839 (95% CI: 0.79-0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.The online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA.ConclusionThe online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA. BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to all patients with hypertension to improve diagnostic efficiency is needed. A novel and portable prediction tool that can expand screening for PA is highly desirable.MethodsClinical characteristics and laboratory data of 1,314 patients with hypertension were collected for modeling and randomly divided into a training cohort (919 of 1,314, 70%) and an internal validation cohort (395 of 1,314, 30%). Additionally, an external dataset (n = 285) was used for model validation. Machine learning algorithms were applied to develop a discriminant model. Sensitivity, specificity, and accuracy were used to evaluate the performance of the model.ResultsSeven independent risk factors for predicting PA were identified, including age, sex, hypokalemia, serum sodium, serum sodium-to-potassium ratio, anion gap, and alkaline urine. The prediction model showed sufficient predictive accuracy, with area under the curve (AUC) values of 0.839 (95% CI: 0.81–0.87), 0.814 (95% CI: 0.77–0.86), and 0.839 (95% CI: 0.79–0.89) in the training set, internal validation, and external validation set, respectively. The calibration curves exhibited good agreement between the predictive risk of the model and the actual risk. An online prediction model was developed to make the model more portable to use.ConclusionThe online prediction model we constructed using conventional clinical characteristics and laboratory tests is portable and reliable. This allowed it to be widely used not only in the hospital but also in community health service centers and may help to improve the diagnostic efficiency of PA. |
Author | Zhong, Liangying Lin, Wenbin Gan, Wenjia Chen, Peisong He, Wanbing Yu, Nan Feng, Pinning Yao, Zhenrong |
AuthorAffiliation | 2 Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China 3 Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University , Guangzhou , China 4 Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University , Guangzhou , China 1 Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University , Guangzhou , China |
AuthorAffiliation_xml | – name: 4 Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University , Guangzhou , China – name: 1 Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University , Guangzhou , China – name: 3 Department of Cardiology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University , Guangzhou , China – name: 2 Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-Sen University , Guangzhou , China |
Author_xml | – sequence: 1 givenname: Wenbin surname: Lin fullname: Lin, Wenbin – sequence: 2 givenname: Wenjia surname: Gan fullname: Gan, Wenjia – sequence: 3 givenname: Pinning surname: Feng fullname: Feng, Pinning – sequence: 4 givenname: Liangying surname: Zhong fullname: Zhong, Liangying – sequence: 5 givenname: Zhenrong surname: Yao fullname: Yao, Zhenrong – sequence: 6 givenname: Peisong surname: Chen fullname: Chen, Peisong – sequence: 7 givenname: Wanbing surname: He fullname: He, Wanbing – sequence: 8 givenname: Nan surname: Yu fullname: Yu, Nan |
BookMark | eNp9kk1v3CAQhq0qVZOm-QG9cezFW75sQw-VolU_IkXKpT0jDOMskQ0u4ET7C_K3i3dXVdNDuYBm5n2GgfdtdeaDh6p6T_CGMSE_DuBt2FBM6UYISrh4VV2QtuU1ZZKe_XU-r65SesBlcUykFG-qc9ZIwRrCLqrnOz86D2iOYJ3JLng0BQsjGkIsQTfpuEd6tCFliMG7NCHn0ayzA58TenJ5h3b7GWIGn1Z1yW53hZgKM8zLqFfmJ3SN8lOoTRFBRBFyDGmG0u8RUMqL3b-rXg96THB12i-rn1-__Nh-r2_vvt1sr29rwznNNdEDkGZgA2lsN1igDDpijeFMCGmo7LHBVPPeWgMYOtl3jeGmNT3lRHLN2GV1c-TaoB_UaUAVtFOHQIj3SsfszAhKQt9K3suuEZQPvZY9N4RrKrq20XIQhfX5yJqXfgK7Dhf1-AL6MuPdTt2HRyWZwFK0BfDhBIjh1wIpq8klA-OoPYQlKdphLtquk7iUkmOpKS-XIgx_2hCsVj-ogx_U6gd19EPRdP9ojMuH_yi3ceN_lL8BNGzBuQ |
CitedBy_id | crossref_primary_10_1016_j_surg_2023_04_063 crossref_primary_10_1038_s41440_023_01374_z crossref_primary_10_1093_jamiaopen_ooae123 crossref_primary_10_1038_s41440_023_01406_8 crossref_primary_10_3389_fendo_2024_1506814 crossref_primary_10_1007_s12553_024_00924_w |
Cites_doi | 10.1210/jc.2015-4061 10.1161/HYPERTENSIONAHA.120.15026 10.1161/HYPERTENSIONAHA.117.10644 10.1161/HYPERTENSIONAHA.117.10263 10.1016/s0002-9343(70)80021-3 10.1016/j.jacc.2006.07.059 10.1182/blood.V49.3.345.345 10.1016/j.jad.2020.09.027 10.1038/hr.2014.20 10.1161/01.CIR.0000153800.09920.40 10.1210/jc.2011-2885 10.1210/jc.2011-2183 10.1245/s10434-013-2871-3 10.1530/eje-17-0990 10.7326/M20-4873 10.1161/CIRCULATIONAHA.115.001593 10.1507/endocrj.ej11-0133 10.1111/j.1365-2265.2007.02775.x 10.1097/HJH.0000000000002510 10.1503/cmaj.161486 10.1097/SLA.0000000000003200 10.1210/jc.2018-01004 10.1161/CIRCULATIONAHA.117.028201 10.1161/HYPERTENSIONAHA.114.03419 10.1046/j.1523-1755.2003.00929.x 10.1210/er.2018-00139 10.1210/clinem/dgaa177 10.1097/HJH.0000000000001511 10.1038/s41371-018-0112-8 10.1016/j.surg.2018.05.085 10.1210/clinem/dgaa379 10.1007/s00259-020-05140-y 10.1620/tjem.84.339 10.1210/jc.2003-031337 10.1161/01.CIR.0000155621.10213.06 10.1681/ASN.V651459 10.3389/fendo.2020.00023 10.1097/HJH.0000000000001088 10.1016/S2213-8587(21)00210-2 10.1161/CIRCULATIONAHA.118.033597 10.1016/j.kint.2020.06.019 10.1210/en.2017-00651 10.1016/S2213-8587(17)30319-4 10.1161/HYPERTENSIONAHA.121.17444 10.1097/01.hjh.0000217857.20241.0f 10.1016/S2213-8587(17)30367-4 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu. Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu |
Copyright_xml | – notice: Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu. – notice: Copyright © 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu 2022 Lin, Gan, Feng, Zhong, Yao, Chen, He and Yu |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fendo.2022.882148 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1664-2392 |
ExternalDocumentID | oai_doaj_org_article_9eb694b975824fba9b4c14a28765a9f8 PMC9380986 10_3389_fendo_2022_882148 |
GrantInformation_xml | – fundername: ; grantid: 2021M703708 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RPM 7X8 5PM |
ID | FETCH-LOGICAL-c442t-1afe15f3f15d7fde23e71dcc43889c29b0c02a4bddce0e79b75c4c6cb24194a33 |
IEDL.DBID | M48 |
ISSN | 1664-2392 |
IngestDate | Wed Aug 27 01:30:50 EDT 2025 Thu Aug 21 17:54:22 EDT 2025 Fri Jul 11 11:36:58 EDT 2025 Tue Jul 01 04:28:09 EDT 2025 Thu Apr 24 23:07:44 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-1afe15f3f15d7fde23e71dcc43889c29b0c02a4bddce0e79b75c4c6cb24194a33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Edited by: Alfredo Scillitani, Home for Relief of Suffering (IRCCS), Italy Reviewed by: Fangli Zhou, Sichuan University, China; Silvia Monticone, University of Turin, Italy This article was submitted to Adrenal Endocrinology, a section of the journal Frontiers in Endocrinology These authors have contributed equally to this work and share first authorship |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fendo.2022.882148 |
PMID | 35983513 |
PQID | 2704867790 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9eb694b975824fba9b4c14a28765a9f8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9380986 proquest_miscellaneous_2704867790 crossref_primary_10_3389_fendo_2022_882148 crossref_citationtrail_10_3389_fendo_2022_882148 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-02 |
PublicationDateYYYYMMDD | 2022-08-02 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-02 day: 02 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in endocrinology (Lausanne) |
PublicationYear | 2022 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Mulatero (B23) 2016; 34 Saiki (B45) 2020; 105 Yamashita (B2) 2018; 36 Na (B27) 2021; 278 Burrello (B30) 2020; 272 Shimamoto (B33) 2014; 37 Kassirer (B35) 1970; 49 Gan (B3) 2019; 33 Williams (B21) 2018; 179 Giacchetti (B43) 2006; 24 Hundemer (B8) 2018; 6 Nishikawa (B19) 2011; 58 Reincke (B42) 2021; 9 Buffolo (B22) 2021; 78 Burrello (B29) 2020; 105 Kline (B17) 2013; 20 Pilz (B12) 2012; 97 Mulatero (B5) 2004; 89 Young (B4) 2007; 66 Nanba (B40) 2018; 103 Taguchi (B41) 2012; 97 Unger (B31) 2020; 75 Chhokar (B11) 2005; 111 Monticone (B9) 2018; 6 Liu (B15) 2018; 71 Ohno (B10) 2018; 71 O'Regan (B46) 1977; 49 Byrd (B1) 2018; 138 Kline (B7) 2017; 189 Mulatero (B20) 2020; 38 Cohen (B25) 2021; 174 Deo (B26) 2015; 132 Liu (B44) 2020; 11 Nanba (B38) 2017; 136 Kuster (B14) 2005; 111 Shioji (B34) 1965; 84 Blasi (B13) 2003; 63 Vaidya (B36) 2018; 39 Mulkerrin (B37) 1995; 6 Rossi (B6) 2006; 48 Funder (B18) 2016; 101 Ruhle (B24) 2019; 165 (B32) 2020; 98 Papp (B28) 2021; 48 Wu (B16) 2018; 159 Fernandes-Rosa (B39) 2014; 64 |
References_xml | – volume: 101 year: 2016 ident: B18 article-title: The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2015-4061 – volume: 75 year: 2020 ident: B31 article-title: International society of hypertension global hypertension practice guidelines publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.120.15026 – volume: 71 year: 2018 ident: B15 article-title: Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.117.10644 – volume: 71 year: 2018 ident: B10 article-title: Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: A multicenter study in Japan publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.117.10263 – volume: 49 year: 1970 ident: B35 article-title: On the pathogenesis of metabolic alkalosis in hyperaldosteronism publication-title: Am J Med doi: 10.1016/s0002-9343(70)80021-3 – volume: 48 year: 2006 ident: B6 article-title: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2006.07.059 – volume: 49 year: 1977 ident: B46 article-title: Electrolyte and acid-base disturbances in the management of leukemia publication-title: Blood doi: 10.1182/blood.V49.3.345.345 – volume: 278 start-page: 1 year: 2021 ident: B27 article-title: Machine learning-based discrimination of panic disorder from other anxiety disorders publication-title: J Affect Disord doi: 10.1016/j.jad.2020.09.027 – volume: 37 start-page: 253 year: 2014 ident: B33 article-title: The Japanese society of hypertension guidelines for the management of hypertension (Jsh 2014) publication-title: Hypertens Res doi: 10.1038/hr.2014.20 – volume: 111 year: 2005 ident: B14 article-title: Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload publication-title: Circulation doi: 10.1161/01.CIR.0000153800.09920.40 – volume: 97 year: 2012 ident: B41 article-title: Expression and mutations of Kcnj5 mrna in Japanese patients with aldosterone-producing adenomas publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-2885 – volume: 97 year: 2012 ident: B12 article-title: Hyperparathyroidism in patients with primary aldosteronism: Cross-sectional and interventional data from the gecoh study publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2011-2183 – volume: 20 year: 2013 ident: B17 article-title: Medical or surgical therapy for primary aldosteronism: Post-treatment follow-up as a surrogate measure of comparative outcomes publication-title: Ann Surg Oncol doi: 10.1245/s10434-013-2871-3 – volume: 179 year: 2018 ident: B21 article-title: Management of endocrine disease: Diagnosis and management of primary aldosteronism: The endocrine society guideline 2016 revisited publication-title: Eur J Endocrinol doi: 10.1530/eje-17-0990 – volume: 174 year: 2021 ident: B25 article-title: Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans : A retrospective cohort study publication-title: Ann Intern Med doi: 10.7326/M20-4873 – volume: 132 year: 2015 ident: B26 article-title: Machine learning in medicine publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.001593 – volume: 58 year: 2011 ident: B19 article-title: Guidelines for the diagnosis and treatment of primary aldosteronism–the Japan endocrine society 2009 publication-title: Endocr J doi: 10.1507/endocrj.ej11-0133 – volume: 66 year: 2007 ident: B4 article-title: Primary aldosteronism: Renaissance of a syndrome publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2007.02775.x – volume: 38 year: 2020 ident: B20 article-title: Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the working group on endocrine hypertension of the European society of hypertension publication-title: J Hypertens doi: 10.1097/HJH.0000000000002510 – volume: 189 year: 2017 ident: B7 article-title: Primary aldosteronism: A common cause of resistant hypertension publication-title: CMAJ doi: 10.1503/cmaj.161486 – volume: 272 year: 2020 ident: B30 article-title: The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism publication-title: Ann Surg doi: 10.1097/SLA.0000000000003200 – volume: 103 year: 2018 ident: B40 article-title: Targeted molecular characterization of aldosterone-producing adenomas in white americans publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2018-01004 – volume: 136 year: 2017 ident: B38 article-title: Age-related autonomous aldosteronism publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.028201 – volume: 64 year: 2014 ident: B39 article-title: Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.114.03419 – volume: 63 year: 2003 ident: B13 article-title: Aldosterone/Salt induces renal inflammation and fibrosis in hypertensive rats publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00929.x – volume: 39 year: 2018 ident: B36 article-title: The expanding spectrum of primary aldosteronism: Implications for diagnosis, pathogenesis, and treatment publication-title: Endocr Rev doi: 10.1210/er.2018-00139 – volume: 105 year: 2020 ident: B45 article-title: Diabetes mellitus itself increases cardio-cerebrovascular risk and renal complications in primary aldosteronism publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgaa177 – volume: 36 year: 2018 ident: B2 article-title: Screening of primary aldosteronism by clinical features and daily laboratory tests: Combination of urine ph, sex, and serum K publication-title: J Hypertens doi: 10.1097/HJH.0000000000001511 – volume: 33 start-page: 57 year: 2019 ident: B3 article-title: High efficiency of the aldosterone-to-Renin ratio in precisely detecting primary aldosteronism publication-title: J Hum Hypertens doi: 10.1038/s41371-018-0112-8 – volume: 165 year: 2019 ident: B24 article-title: Keeping primary aldosteronism in mind: Deficiencies in screening at-risk hypertensives publication-title: Surgery doi: 10.1016/j.surg.2018.05.085 – volume: 105 year: 2020 ident: B29 article-title: Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgaa379 – volume: 48 year: 2021 ident: B28 article-title: Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [(68)Ga]Ga-Psma-11 Pet/Mri publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-020-05140-y – volume: 84 year: 1965 ident: B34 article-title: Effects of salt restriction, spironolactone, and ammonium chloride on acid-base relations in a case of primary aldosteronism publication-title: Tohoku J Exp Med doi: 10.1620/tjem.84.339 – volume: 89 year: 2004 ident: B5 article-title: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2003-031337 – volume: 111 year: 2005 ident: B11 article-title: Hyperparathyroidism and the calcium paradox of aldosteronism publication-title: Circulation doi: 10.1161/01.CIR.0000155621.10213.06 – volume: 6 year: 1995 ident: B37 article-title: Aldosterone responses to hyperkalemia in healthy elderly humans publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V651459 – volume: 11 year: 2020 ident: B44 article-title: Higher blood urea nitrogen and urinary calcium: New risk factors for diabetes mellitus in primary aldosteronism patients publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2020.00023 – volume: 34 year: 2016 ident: B23 article-title: Guidelines for primary aldosteronism: Uptake by primary care physicians in Europe publication-title: J Hypertens doi: 10.1097/HJH.0000000000001088 – volume: 9 year: 2021 ident: B42 article-title: Diagnosis and treatment of primary aldosteronism publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(21)00210-2 – volume: 138 year: 2018 ident: B1 article-title: Primary aldosteronism: Practical approach to diagnosis and management publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.033597 – volume: 98 start-page: S1 year: 2020 ident: B32 article-title: KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease publication-title: Kidney Int doi: 10.1016/j.kint.2020.06.019 – volume: 159 year: 2018 ident: B16 article-title: Inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma publication-title: Endocrinology doi: 10.1210/en.2017-00651 – volume: 6 start-page: 41 year: 2018 ident: B9 article-title: Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(17)30319-4 – volume: 78 year: 2021 ident: B22 article-title: Clinical score and machine learning-based model to predict diagnosis of primary aldosteronism in arterial hypertension publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.121.17444 – volume: 24 year: 2006 ident: B43 article-title: Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: Need for a standardized protocol publication-title: J Hypertens doi: 10.1097/01.hjh.0000217857.20241.0f – volume: 6 year: 2018 ident: B8 article-title: Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(17)30367-4 |
SSID | ssj0000401998 |
Score | 2.3313344 |
Snippet | The prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening for PA to... BackgroundThe prevalence of primary aldosteronism (PA) varies from 5% to 20% in patients with hypertension but is largely underdiagnosed. Expanding screening... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 882148 |
SubjectTerms | Endocrinology hypertension online prediction model primary aldosteronism primary care risk factors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yB_EiPnF9EcGTUGzTtGm8qbgsgp4UvIUkTVFYW2kr_gT_tjNpd2kvevGaR5tkJpmZZOYbQs6dSFgGx35gOVg6sBML2FJCBGDfshzEZxoZvNB_eEznz_z-JXkZpPpCn7AOHrhbuEvpTCq5kaDXMl4YLQ23Edeg6KeJloUP8wWZNzCm_BkMZgMYEt0zJlhh8rJwZY7BfowBb7AI8_0MBJHH6x8pmWMXyYHMmW2RzV5ZpNfdILfJmit3yPpD_xy-S747oFD6UWMRLjH1mW0oaKJQ6HEkqF7kGMiBGLjNO30raQ-l2lC8g6WvYIjW3o0dekMtJtR2DXxzldnril7T9qsKcJCuprVr62oZoEk9PO0eeZ7dPd3Ogz6zApCEszaIdOGipIiLKMlFkTsWOxHl1vI4y6Rl0oQ2ZJqbHOYfOiGNSCy3qTUg7yXXcbxPJmVVugNCJZdWpzwLM865iNMMFEohNMt1bHQkwikJl8usbA87jtkvFgrMD6SM8pRRSBnVUWZKLlZd-rX6rfEN0m7VEOGyfQEwkeqZSP3FRFNytqS8gu2Fbya6dNVno5jwmIRCwkTEiCVGfxzXlG-vHqhbxlkos_TwP4Z4RDZw1t73kB2TSVt_uhPQh1pz6ln_B2PYDMo priority: 102 providerName: Directory of Open Access Journals |
Title | Online prediction model for primary aldosteronism in patients with hypertension in Chinese population: A two-center retrospective study |
URI | https://www.proquest.com/docview/2704867790 https://pubmed.ncbi.nlm.nih.gov/PMC9380986 https://doaj.org/article/9eb694b975824fba9b4c14a28765a9f8 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fa9UwFA5zA_Fl6FTcdCODPQnVJk2TRhCZ4jYG1ycv3LeQpKkb3LXadqh_wf5tz8nNvVgY4ksf0jZt8vX0nC8_vkPISVAlr-C3n3kBTAcssQGTUioDfstrcJ-SORzQn32RF3NxuSgXW2Sd3ip14HAvtcN8UvN--ebXj98fwODfI-MEf_u2CW2N-_g4B9g5xPcPyA44JoUJDWYp2o8_ZuASOmbHZVKKjENosJrnvL-WiaeKgv6TKHS6hvIvp3T2mOymaJKeruB_QrZCu0ceztJ8-VNyt1ISpd97LEIMaEx9QyFUhcIoNEHtssadHiiSO9zQ65YmrdWB4iAtvQKm2sd17nA3nMWM22GAOjepv97RUzr-7DJ8ydDTPox9t97BSaN-7TMyP_v89dNFllIvAGaCjxmzTWBlUzSsrFVTB14ExWrvRVFV2nPtcp9zK1wN7c-D0k6VXnjpHfS7FrYonpPttmvDC0K10N5KUeWVEEIVsoKIUynLa1s4y1S-T_J1NxufdMkxPcbSAD9BZExExiAyZoXMPnm9uSX11b8u_ojYbS5EPe1Y0PXfTDJPo4OTWjgN7ImLxlnthGfCAp2UpdUNVHK8Rt6A_eGkim1DdzsYrqJoodLQEDX5JCZPnJ5pr6-ikrcuqlxX8uA_an9JHmGj4tpD_opsj_1tOIR4aHRHcRwBjucLdhS_-D95Vg4J |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Online+prediction+model+for+primary+aldosteronism+in+patients+with+hypertension+in+Chinese+population%3A+A+two-center+retrospective+study&rft.jtitle=Frontiers+in+endocrinology+%28Lausanne%29&rft.au=Lin%2C+Wenbin&rft.au=Gan%2C+Wenjia&rft.au=Feng%2C+Pinning&rft.au=Zhong%2C+Liangying&rft.date=2022-08-02&rft.issn=1664-2392&rft.eissn=1664-2392&rft.volume=13&rft.spage=882148&rft_id=info:doi/10.3389%2Ffendo.2022.882148&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-2392&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-2392&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-2392&client=summon |